Farmaci antipertensivi a confronto: costi e benefici per il paziente e la collettività
Pharmacoeconomic analysis of antihypertensive treatment should be performed following a correct methodological evaluation and considering with accuracy both costs and benefits of different therapeutic options. Costs evaluation is frequently performed simply examining the retail price of drugs which...
Main Author: | Francesco Vittorio Costa |
---|---|
Format: | Article |
Language: | English |
Published: |
SEEd Medical Publishers
2003-12-01
|
Series: | Farmeconomia: Health Economics and Therapeutic Pathways |
Online Access: | https://journals.seedmedicalpublishers.com/index.php/FE/article/view/779 |
Similar Items
-
Come avviare la terapia nel paziente naïve: Scelta dei farmaci sulle caratteristiche della malattia e del paziente
by: Massimiliano Mirabella
Published: (2015-12-01) -
Verso un'analisi costi benefici «ambientale»
by: Marta Bottero
Published: (2009-06-01) -
Farmaci innovativi e sostenibilità
by: Paolo Bonaretti
Published: (2016-09-01) -
Farmaci e bioetica in nefrologia
by: Mario Timio, et al.
Published: (2016-02-01) -
Il valore di non uso nell'analisi costi benefici della salvaguardia ambientale
by: Anna Alberini, et al.
Published: (2009-06-01)